Protagonist Therapeutics Inc (PTGX)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	434,433	323,795	319,120	314,953	60,000	0	0	859	26,581	35,198	45,484	46,890	27,357	24,390	27,218	31,170	28,628	25,697	16,724	2,318
Total assets	US$ in thousands	744,725	603,857	614,629	629,276	357,951	330,016	320,466	239,858	247,928	282,174	310,512	348,296	347,695	373,175	404,232	298,072	324,468	217,320	224,980	134,901
Total asset turnover		0.58	0.54	0.52	0.50	0.17	0.00	0.00	0.00	0.11	0.12	0.15	0.13	0.08	0.07	0.07	0.10	0.09	0.12	0.07	0.02

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $434,433K ÷ $744,725K
= 0.58

Protagonist Therapeutics Inc's total asset turnover has shown considerable fluctuation over the analyzed period. The ratio increased from 0.02 at March 31, 2020, to peak at 0.58 by December 31, 2024. The company's ability to generate sales revenue from its total assets has been improving over time, indicating better efficiency in asset utilization. However, there were periods such as March 31, 2023, June 30, 2023, and September 30, 2023, where the total asset turnover was at 0.00, suggesting potential challenges in generating sales from assets during those quarters. Overall, the upward trend in total asset turnover reflects positively on Protagonist Therapeutics Inc's operational performance and efficiency in utilizing its assets to drive revenue.